- Oasis-HT: design of a pharmacogenomic dose-finding study2005 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Oasis-HT: design of a pharmacogenomic dose-finding study2005 | Faculty of Medicine in Pilsen
- Intravenous immunoglobulin in relapsing-remitting multiple sclerosis - A dose-finding trial2008 | Second Faculty of Medicine
- Effects of AZD3480 on Cognition in Patients with Mild-to-Moderate Alzheimer's Disease: A Phase IIb Dose-Finding Study2011 | Second Faculty of Medicine
- A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II study2016 | Faculty of Medicine in Pilsen
- Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study2022 | Publication without faculty affiliation
- Research Report University Hospital for clinical assessment TPU-S1119Publication without faculty affiliation
- Steps Toward Harmonization for Clinical Development of Medicines in Pediatric Ulcerative Colitis - A Global Scientific Discussion, Part 1: Efficacy Endpoints and Disease Outcome Assessments2014 | First Faculty of Medicine
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. 11-AVR-130Publication without faculty affiliation
- Report of University Hospital Hradec Králové to the clinical trial protocol No: BAY 15371Publication without faculty affiliation
- Bridging Antiplatelet Therapy With Cangrelor in Patients Undergoing Cardiac Surgery A Randomized Controlled Trial2012 | Publication without faculty affiliation
- Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia2022 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové